S

Southern Acids (M) Bhd
KLSE:SAB

Watchlist Manager
Southern Acids (M) Bhd
KLSE:SAB
Watchlist
Price: 3.1 MYR -0.64% Market Closed
Market Cap: 424.5m MYR
Have any thoughts about
Southern Acids (M) Bhd?
Write Note

Intrinsic Value

The intrinsic value of one SAB stock under the Base Case scenario is 3.42 MYR. Compared to the current market price of 3.1 MYR, Southern Acids (M) Bhd is Undervalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SAB Intrinsic Value
3.42 MYR
Undervaluation 9%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Southern Acids (M) Bhd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SAB?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Chemicals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Southern Acids (M) Bhd

Provide an overview of the primary business activities
of Southern Acids (M) Bhd.

What unique competitive advantages
does Southern Acids (M) Bhd hold over its rivals?

What risks and challenges
does Southern Acids (M) Bhd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Southern Acids (M) Bhd.

Provide P/S
for Southern Acids (M) Bhd.

Provide P/E
for Southern Acids (M) Bhd.

Provide P/OCF
for Southern Acids (M) Bhd.

Provide P/FCFE
for Southern Acids (M) Bhd.

Provide P/B
for Southern Acids (M) Bhd.

Provide EV/S
for Southern Acids (M) Bhd.

Provide EV/GP
for Southern Acids (M) Bhd.

Provide EV/EBITDA
for Southern Acids (M) Bhd.

Provide EV/EBIT
for Southern Acids (M) Bhd.

Provide EV/OCF
for Southern Acids (M) Bhd.

Provide EV/FCFF
for Southern Acids (M) Bhd.

Provide EV/IC
for Southern Acids (M) Bhd.

What are the Revenue projections
for Southern Acids (M) Bhd?

How accurate were the past Revenue estimates
for Southern Acids (M) Bhd?

What are the Net Income projections
for Southern Acids (M) Bhd?

How accurate were the past Net Income estimates
for Southern Acids (M) Bhd?

What are the EPS projections
for Southern Acids (M) Bhd?

How accurate were the past EPS estimates
for Southern Acids (M) Bhd?

What are the EBIT projections
for Southern Acids (M) Bhd?

How accurate were the past EBIT estimates
for Southern Acids (M) Bhd?

Compare the revenue forecasts
for Southern Acids (M) Bhd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Southern Acids (M) Bhd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Southern Acids (M) Bhd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Southern Acids (M) Bhd compared to its peers.

Compare the P/E ratios
of Southern Acids (M) Bhd against its peers.

Discuss the investment returns and shareholder value creation
comparing Southern Acids (M) Bhd with its peers.

Analyze the financial leverage
of Southern Acids (M) Bhd compared to its main competitors.

Show all profitability ratios
for Southern Acids (M) Bhd.

Provide ROE
for Southern Acids (M) Bhd.

Provide ROA
for Southern Acids (M) Bhd.

Provide ROIC
for Southern Acids (M) Bhd.

Provide ROCE
for Southern Acids (M) Bhd.

Provide Gross Margin
for Southern Acids (M) Bhd.

Provide Operating Margin
for Southern Acids (M) Bhd.

Provide Net Margin
for Southern Acids (M) Bhd.

Provide FCF Margin
for Southern Acids (M) Bhd.

Show all solvency ratios
for Southern Acids (M) Bhd.

Provide D/E Ratio
for Southern Acids (M) Bhd.

Provide D/A Ratio
for Southern Acids (M) Bhd.

Provide Interest Coverage Ratio
for Southern Acids (M) Bhd.

Provide Altman Z-Score Ratio
for Southern Acids (M) Bhd.

Provide Quick Ratio
for Southern Acids (M) Bhd.

Provide Current Ratio
for Southern Acids (M) Bhd.

Provide Cash Ratio
for Southern Acids (M) Bhd.

What is the historical Revenue growth
over the last 5 years for Southern Acids (M) Bhd?

What is the historical Net Income growth
over the last 5 years for Southern Acids (M) Bhd?

What is the current Free Cash Flow
of Southern Acids (M) Bhd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Southern Acids (M) Bhd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Southern Acids (M) Bhd

Current Assets 612.7m
Cash & Short-Term Investments 580.4m
Receivables 117.4m
Other Current Assets -85.1m
Non-Current Assets 406.2m
Long-Term Investments 191.7m
PP&E 212.5m
Other Non-Current Assets 2m
Current Liabilities 102.7m
Accounts Payable 31.6m
Other Current Liabilities 71m
Non-Current Liabilities 136.7m
Long-Term Debt 2.1m
Other Non-Current Liabilities 134.6m
Efficiency

Earnings Waterfall
Southern Acids (M) Bhd

Revenue
933.7m MYR
Cost of Revenue
-837.1m MYR
Gross Profit
96.6m MYR
Operating Expenses
-61.2m MYR
Operating Income
35.4m MYR
Other Expenses
-29.2m MYR
Net Income
6.2m MYR

Free Cash Flow Analysis
Southern Acids (M) Bhd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SAB Profitability Score
Profitability Due Diligence

Southern Acids (M) Bhd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 3-Year Average ROIC
47/100
Profitability
Score

Southern Acids (M) Bhd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

SAB Solvency Score
Solvency Due Diligence

Southern Acids (M) Bhd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
91/100
Solvency
Score

Southern Acids (M) Bhd's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SAB Price Targets Summary
Southern Acids (M) Bhd

There are no price targets for SAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SAB?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Southern Acids (M) Bhd

Country

Malaysia

Industry

Chemicals

Market Cap

424.5m MYR

Dividend Yield

1.61%

Description

Southern Acids (Malaysia) Bhd.is an investment holding company, which engages in the provision of management services to its subsidiaries. The company is headquartered in Klang, Selangor and currently employs 1,671 full-time employees. The firm's segments include Oleochemical segment, Milling & Estate segment and Healthcare segment. The Oleochemical segment is involved in manufacturing and marketing of fatty acids and glycerin. The Oleochemical segment offers its products to end- use applications, such as personal care, cleaning agents and food products. The Milling & Estate segment is engaged in processing of Fresh Fruit Bunches (FFB) into crude palm oil and oil palm cultivation. The Healthcare segment operates in the private healthcare space. The firm's subsidiaries include Southern Acids (M) Berhad Sdn. Bhd., Southern Acids Industries Sdn. Bhd., PKE Transport (Malaysia) Sdn. Bhd., Pembinaan Gejati Sdn. Bhd, Sab Properties Development Co. Sdn. Berhad, Noble Interest Sdn. Bhd., Southern Medicare Sdn. Bhd., Wilstar Sdn. Bhd, SAB Plantation Sdn. Bhd and Firstview Development Sdn. Bhd.

Contact

SELANGOR
Klang
Level 29, Centro Tower, No. 8, Jalan Batu Tiga Lama
+60332583333
www.southernacids.com

IPO

1991-07-10

Employees

1 671

Officers

MD & Non-Independent Executive Director
Dr. Kok Thye Low
Non-Independent Executive Director
Mr. Kim Long Lim
Chief Financial Officer
Mr. Kee Yoong Cheong
General Manager of Operations, Milling & Cultivation
Mr. Thevakumar Kaliaperumal
Chief Operating Officer of Oleochemical Manufacturing Segment
Mr. Chuu Ling Tiong
Chief Strategic Development Officer
Mr. Choon Hoong Chan
Show More
Company Secretary
Shu Ling Ng
Show Less

See Also

Discover More
What is the Intrinsic Value of one SAB stock?

The intrinsic value of one SAB stock under the Base Case scenario is 3.42 MYR.

Is SAB stock undervalued or overvalued?

Compared to the current market price of 3.1 MYR, Southern Acids (M) Bhd is Undervalued by 9%.

Back to Top